In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Mindray nets $151.2mm though public sale of ADSs

Executive Summary

Mindray Medical International Ltd. (monitoring devices, in vitro diagnostics, and imaging equipment) netted $151.2mm through the public offering of 4mm ADSs (equal to 4mm Class A ordinary shares) at $38.20 each.
Deal Industry
  • In Vitro Diagnostics
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
    • Diagnostic Imaging Equipment & Supplies
      • Ultrasound
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

UsernamePublicRestriction

Register